Customer

/We sincerely thank our globally renowned clients in the life sciences and healthcare sectors—including AstraZeneca, Siemens Healthineers, Qilu Pharmaceutical, and GE Healthcare—for your trust and high recognition. Your affirmation is the greatest driving force behind Glyph Translation’s continued dedication to pharmaceutical translation and its commitment to professionalism, compliance, and confidentiality. Looking ahead, we will continue to strengthen our capabilities across 65+ languages and further enhance our service advantages in core areas such as eCTD, DMF, and patents. With more precise terminology management, more rigorous compliance adaptation, and more efficient end-to-end responsiveness, we will help our partners overcome geographic and language barriers, accelerate global market access and research commercialization, and work together to advance innovation and health outcomes across the life sciences sector.

Kangtai Biological Products

The translation of vaccine production batch records and quality standards demands strict attention to detail. Glyph Translation's translations provided meticulous descriptions of process parameters and testing methods, with unified terminology and zero deviation. Their timely response to remediation translations for GMP audits helped us successfully pass multiple domestic and international audits. They are highly trustworthy!

Jafron Biomedical

The translation of GMP documents and registration dossiers for blood purification products is highly specialized. Glyph Translation's translators deeply understood the product processes and regulatory requirements. The translation of manufacturing workflows and quality standards was precise and error-free. Supplementary revisions for NMPA registration were completed within 24 hours, helping our products gain rapid approval and launch.

Otsuka Pharmaceutical

We focus on the fields of psychiatry and neurology, oncology, and cardiovascular and renal diseases, with frequent needs for overseas submissions and multilingual documents. Glyph Translation's translation of psychiatric drug package inserts and cancer immunotherapy R&D materials was professional and authentic, strictly adhering to PMDA standards and overseas regulatory requirements. The clinical data logic was coherent, and the terminology was precise. The project team responded rapidly and executed confidentiality measures thoroughly, providing stable and reliable translation support for our global business expansion. The collaboration was worry-free and highly efficient!

Novo Nordisk

The translation requirements for drug registration dossiers in the diabetes field are extremely high. Glyph Translation's translators are not only familiar with relevant pharmacological knowledge but also precisely adapt to the FDA's regulatory expression habits. The translation of clinical trial data and pharmacokinetic parameters was rigorous, and the bilingual side-by-side versions facilitated our internal review. The submission process went very smoothly.

Mitsubishi Tanabe Pharma

As a Japanese pharmaceutical company deeply engaged in fields such as the central nervous system, immune-inflammation, and renal anemia, we have stringent compliance and professionalism requirements for the translation of PMDA/JNDA submission dossiers. Glyph Translation precisely completed the translation of Clinical Trial Reports and market authorization application documents for ALS treatments and the new renal anemia drug Vadadustat. The Japanese translations authentically adapted to the standards of the Ministry of Health, Labour and Welfare, with zero deviation in clinical data and process terminology. Confidentiality measures were rigorous, and they also assisted in interpreting regulatory differences in cross-national submissions, helping multiple new drugs of ours gain successful approval and expand into global markets. The collaboration is professional and trustworthy!

Fosun Pharma

GMP documents cover the entire manufacturing process, with complex terminology and high standard requirements. Glyph Translation not only efficiently completed the translation of all documents but also proactively helped us organize our exclusive corporate termbase, unifying the translation of process terminology and quality standards. The efficiency of our subsequent collaborations has significantly improved, saving us both worry and effort!

AstraZeneca

Glyph Translation's translation of full-module eCTD dossiers is an industry benchmark! Not only does it precisely adapt to the dual regulatory standards of the FDA and EMA, but terminology consistency is also 100%. Even with a 3-day expedited delivery for a 10,000-word clinical summary report, there were zero errors. The project team synchronized progress in real time throughout the process, helping us significantly shorten our global submission cycle. They are a core partner worthy of long-term commitment.

Medtronic

The supporting translation for eCTD validation is a difficult point in submissions, and Glyph Translation's team knows the formatting requirements of various regulatory systems inside out. The metadata translations matched accurately, and cross-references between modules were unbroken, helping us avoid multiple potential risks of submission rejection and making the entire electronic submission process smooth and unimpeded.

Siemens Healthineers

As a company deeply engaged in the medical device sector, we have extremely high requirements for the professionalism of technical document translation. Glyph Translation perfectly restored the complex formatting of our medical device operation manuals. The translation of core component terminology and performance parameters was precise and error-free. Their response to supplementary revisions for NMPA registration reviews was within 24 hours without any delay. The collaboration experience far exceeded our expectations!

Qilu Pharmaceutical

During the critical stage of our DMF submission to the EU, Glyph Translation's services gave us full confidence. The translators thoroughly understood EMA technical specifications, and the translation of pharmaceutical research data and manufacturing process descriptions was rigorous and compliant. After delivery, they proactively assisted in interpreting regulatory feedback and targetedly optimized the translation. Ultimately, we successfully obtained the EU registration code. They are truly reliable!

GE Healthcare

The translation needs for multi-regional clinical evaluation reports were complex, involving four languages: Chinese, English, German, and Japanese. Glyph Translation's performance was amazing. The translations not only conformed to the regulatory expression habits of each target region but also maintained the coherence of data logic. The exclusive termbase was fully synchronized with our corporate standards, directly increasing our cross-country submission efficiency by 50%!

Boston Scientific

Patent translation for Medical Devices demands strict legal rigor and technical precision, and Glyph Translation achieved both. There was zero deviation in the translation of core expressions in the claims and details of compound preparation methods. Their confidentiality measures were watertight, with zero leakage of undisclosed technical data throughout the process. They are a reassuring choice for our patent submissions.

Carl Zeiss Meditec

Translating academic papers in the ophthalmology field is quite difficult, as many cutting-edge technical terms lack unified translations. Glyph Translation's translators not only possess a solid professional background in ophthalmology but also precisely balance academic rigor with the expression habits of SCI journals. Our paper passed the review on the first submission, saving us a massive amount of revision time.

Daiichi Sankyo

As a global innovative pharmaceutical company deeply engaged in the oncology field, the global submission of our ADC drugs (such as T-DXd and Dato-DXd) requires extremely high translation precision and compliance. Glyph Translation perfectly completed the multilingual translation of Clinical Trial Reports and NDA/BLA submission dossiers, precisely adapting to the quadruple standards of the NMPA, FDA, EMA, and PMDA. The core technical terminology of ADC drugs was unified without deviation, and confidentiality measures were rigorous. They also assisted in interpreting cross-national regulatory differences, helping multiple innovative drugs like Enhertu® successfully enter the global market. Their professional capabilities are impeccable!

Chia Tai Tianqing

Deeply engaged in the fields of liver disease and oncology drugs, our overseas submission needs are frequent and stringent. Glyph Translation's translation of DMF files and IND application materials perfectly adapted to FDA/EMA standards. The translation of terminology related to innovative oncology drugs was precise, and the clinical data logic was coherent. They also assisted in interpreting overseas regulatory feedback, providing critical support for the successful launch of products like Penpulimab in European and American markets. The collaboration was professional and worry-free!

Sinopharm

The translation needs for multi-regional registration dossiers were scattered, involving multiple languages such as Chinese, English, Spanish, and Russian. Glyph Translation's multilingual team responded rapidly, and the translations for each language complied with local regulatory standards. There were no review issues caused by differences in expression habits, and the submission pass rate remained at the forefront of the industry.